SLC44A5
Choline transporter-like protein 5
Also known as: CTL5, CTL5_HUMAN, MGC34032
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NCS7
- Gene
- SLC44A5
- Ensembl
- ENSG00000137968
- Chromosome
- 1
- Canonical length
- 719 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables choline transmembrane transporter activity. Involved in choline transport. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
719 residues, UniProt reviewed canonical sequence.
>Q8NCS7|SLC44A5
1 MNDTEKPADT PSEEEDFGDP RTYDPDFKGP VANRSCTDVL CCMIFLLCII GYIVLGLVAW
61 VHGDPRRAAY PTDSQGHFCG QKGTPNENKT ILFYFNLLRC TSPSVLLNLQ CPTTQICVSK
121 CPEKFLTYVE MQLLYTKDKS YWEDYRQFCK TTAKPVKSLT QLLLDDDCPT AIFPSKPFLQ
181 RCFPDFSTKN GTLTIGSKMM FQDGNGGTRS VVELGIAANG INKLLDAKSL GLKVFEDYAR
241 TWYWILIGLT IAMVLSWIFL ILLRFIAGCL FWVFMIGVIG IIGYGIWHCY QQYTNLQERP
301 SSVLTIYDIG IQTNISMYFE LQQTWFTFMI ILCIIEVIVI LMLIFLRNRI RVAIILLKEG
361 SKAIGYVPST LVYPALTFIL LSICICYWVV TAVFLATSGV PVYKVIAPGG HCIHENQTCD
421 PEIFNTTEIA KACPGALCNF AFYGGKSLYH QYIPTFHVYN LFVFLWLINF VIALGQCALA
481 GAFATYYWAM KKPDDIPRYP LFTAFGRAIR YHTGSLAFGS LIIALIQMFK IVLEYLDHRL
541 KRTQNTLSKF LQCCLRCCFW CLENAIKFLN RNAYIMIAIY GRNFCRSAKD AFNLLMRNVL
601 KVAVTDEVTY FVLFLGKLLV AGSIGVLAFL FFTQRLPVIA QGPASLNYYW VPLLTVIFGS
661 YLIAHGFFSV YAMCVETIFI CFCEDLERND GSTEKPYFVT PNLHGILIKK QLVPQKQKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC44A5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- skin: 10 nTPM
- esophagus: 6.2 nTPM
- breast: 5.2 nTPM
- testis: 4.2 nTPM
- placenta: 3.6 nTPM
- parathyroid gland: 3.5 nTPM
Single-cell type
- gonadotrophs: 919 nCPM
- other brain neurons: 368 nCPM
- oligodendrocyte progenitor cells: 366 nCPM
- thyrotrophs: 319 nCPM
- thymic myoid cells: 284 nCPM
- early spermatids: 279 nCPM
Immune cell
- memory B-cell: 0.7 nTPM
- naive B-cell: 0.4 nTPM
- memory CD8 T-cell: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- naive CD4 T-cell: 0.1 nTPM
Brain region
- cerebral cortex: 10 nTPM
- pons: 8.9 nTPM
- thalamus: 8.1 nTPM
- spinal cord: 7.7 nTPM
- hypothalamus: 7.1 nTPM
- medulla oblongata: 6.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.18
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC44A5 as an antibody target. Whether an autoantibody or antibody against SLC44A5 could matter depends on whether native SLC44A5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC44A5 is annotated at the cell surface, where native SLC44A5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC44A5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...